Kanda, Eiichiro
Suzuki, Atsushi
Makino, Masaki
Tsubota, Hiroo
Kanemata, Satomi
Shirakawa, Koichi
Yajima, Toshitaka
Funding for this research was provided by:
AstraZeneca K.K.
Ono Pharmaceutical Co., Ltd
Article History
Received: 14 September 2022
Accepted: 17 November 2022
First Online: 21 November 2022
Competing interests
: H.T., K.S., and T.Y. are full-time employees of AstraZeneca K.K., S.K. is a full-time employee of Ono Pharmaceutical Co., Ltd. E.K., A.S., and M.M. declare no potential conflict of interest.